Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan-Feb;117(1):59-64.

Medications for Opioid Use Disorder: A Guide for Physicians

Affiliations
Review

Medications for Opioid Use Disorder: A Guide for Physicians

Naazia Azhar et al. Mo Med. 2020 Jan-Feb.

Abstract

The opioid crisis has shaped the national public health dialogue for some time now. A "call to action" is a strong and resounding cry from multiple disciplines. This piece intends to detail the nuts and bolts of prescribing medications used for the treatment of opioid use disorder. The underlying message here is that opioid use disorder is a chronic, treatable illness and physicians of all specialties have a responsibility to not turn a blind eye.

PubMed Disclaimer

Figures

Figure 1
Figure 1
DSM 5 criteria for OUD
None

References

    1. Lewis L, Carpenter CR, Schwarz ES, et al. The Opioid Crisis in Missouri: A Call to Action for Physicians, Legislators, and Society. Mo Med. 2017;114(6):440–446. - PMC - PubMed
    1. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209. doi: 10.1002/14651858.CD002209.pub2. - DOI - PMC - PubMed
    1. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207. doi: 10.1002/14651858.CD002207.pub4. - DOI - PMC - PubMed
    1. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017 doi: 10.1136/bmj.j1550. - DOI - PMC - PubMed
    1. Ducharme J, Moore S. Opioid Use Disorder Assessment Tools and Drug Screening. Mo Medicine. 2019;116(4):318–324. - PMC - PubMed

MeSH terms